Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Scanfil, Q2'24

By Inderes8/6/2024, 7:00 AM
Scanfil

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Pasi Hiedanpää
00:00 - 00:37

Good morning. My name is Pasi Hiedanpää, and I'm the Director of Investor Relations and Communications. That's Scanfil plc. Welcome to our Q2 2024 results webcast here with me and our CEO, Christophe Sut, and our CFO, Kai Valo. All the questions you have can be entered in the chat box, and they will all be answered at the end of the presentation. So in the Q&A session. But hey, welcome, Christoph. And the floor is yours. Thank you.

Christophe Sut
00:40 - 11:00

Thank you, Pasi. Welcome to all of you. And let's start. Going into an overview of Q2, as we had communicated before, Q2 faced very high comparables. So we landed in revenue at €195.5 million, which was a -19.7%, pretty much in line with what we were expecting from the quarter. Therefore, I will say the main focus of the quarter was to defend profitability in a market that was more volatile and more challenging. And there I think that we did a good job maintaining €13.9 million of operating profit, which was 7.1% in line, actually, with our long-term target corridors that we communicated earlier in our capital market day earlier in the year. It was quite pleasing to come to that level of profit in such market conditions. As I mentioned, turnover was declining, which was expected. However, during the quarter we started to see signs of recovery in one of the market segments we have, which is Medtech & Life Science. I will explain a bit more about it later. We realized the outcome of the efficiency program we had put in place and worked on already last quarter last year, and it came into full action during this quarter. It allowed us to balance the revenue by lowering costs. We also continued the work we had on improving our working capital, reducing inventory, which had a positive effect on our cash position. At the same time, even if we were in a defensive mode regarding costs and delivering profitability, we continued to work on strategic initiatives we had launched earlier. Both Dream Factory implementation and the commercial plan we have with implementation of our three segments are now fully in place and working towards our customer and also acquiring new contracts. So, a lot of activities, and looking at a few key events, were significant in the quarter. We won a project worth €40 million. And I will go a bit more in detail later. But we have now decided that we will, on a quarterly basis, give you the number of projects won when we get them in the company. So 40 million was a solid number and a few contracts came on board. The one we have here on the screen is the contract we signed with Framery, where we are actually doing system integration and building those small offices that you can see in the picture. So, it's an exciting, very exciting business. We are very proud to become a supplier for those customers and to bring new solutions to life in the market for them, as well as drive development. Our management team is evolving, and we are pleased with the progress. We were happy to announce during the quarter that Anette Mullis will join us as Chief People Officer. At this stage, where our focus is on growing the company and building competencies, it's crucial. So, Anita is definitely the right profile with the experience we believe will help us move forward. We also continue to concentrate on quality delivery. On-time delivery was again above 98% for the quarter, which was very pleasing. We were very gratified to be recognized for our work. Our Dream Factory was praised by Danfoss Sensing Solutions for the outstanding performance. It was particularly gratifying to share this because it materializes what we have been discussing regarding the performance of our deliveries and how people appreciate the results of our programs. Furthermore, we are gaining momentum in manufacturing electronic components in Atlanta, with several new customers utilizing our facilities there. This progress is step by step and gaining momentum, recalling the key investments we made last year. There were several events during that quarter that were quite pleasing to see, even considering the market conditions; for instance, our revenue development, as mentioned previously, reached approximately €95.5 million. From a supply perspective, we now have very few Price Volume Variance (PPV) issues affecting our revenue. Now, our revenue increasingly comes from product delivery and added value. This aspect has normalized over time. Regarding operating profit, as mentioned earlier, it was heartening to see that we reached €13.9 million in operating profit. This represents one of the top four quarterly profits in terms of profitability and value for Scanfil, which, given the market conditions, is quite pleasing. The 7.1% operating margin also fell within our targeted margin range. A big thanks to all our teams who have continuously worked on enhancing efficiency and maintaining control over the cost base, which is always reassuring to see no matter the business cycle. At the same time, we continue to diversify our customer portfolio. Today, our largest customer makes up 12% of our business, and the top ten, excluding the largest, account for 42%. We have a very well-balanced portfolio, which is beneficial as it provides us with long-term stability and potential growth opportunities. Many of these customers, who do not fully own their manufacturing needs, are growing daily. This growth presents new opportunities as we move forward. Looking at the different segments now, on the revenue side, the industrial sector declined 19.6% during the quarter, which was, as previously stated, somewhat anticipated. We had very high comparables from the previous year. And we believe that last year was somewhat of a bubble quarter, with component shortages and supply chain panic. Thus, it declined by 19.6%. Looking at the first half of the year, we achieved revenue of about €35 million in that sector, which we believe is conducive to future growth. We have acquired a few sizable contracts, bringing in a decent segment with about 13 million. If you put them together, that will actually be materializing in 6 to 18 months, depending on which contract we are talking about. So, those were the developments we had in the quarter. Moving now to Energy & Cleantech. Energy & Cleantech declined 26.1% in the quarter. And they are more prevalent than anywhere else. I mean, we were really facing a bubble quarter last year, and therefore I think that we should view those numbers with a critical eye and feel like, okay, this is what it was. What is interesting to see, however, are two things: the dynamics. We continue to see new projects. During that quarter, we secured 22 million in new contracts for that segment. Since the beginning of the year, we have secured €38 million in new contracts. And I think it shows two things. It shows the long-term dynamics of these sectors that are clearly going to continue to grow and develop over the long term. And it also shows that we are seen as a very reliable partner. Supplier in that sector with the value we acquired in the quarter. So, it's a positive development. We can only say we gained customers in that segment. There is no loss of customers. They move to us more and more, transferring more products to us from existing customers, and new customers also come on board. So that was the outcome of those new rounds we had. And then, Medtech & Life Science was declining by 4.9% in the quarter. Uh, which was, I will say, getting very close to stabilization in numbers. And in reality, when you look at the dynamics of the quarter. I mean, we had a slight rebound towards the end of the quarter. The same goes for acquiring new projects, where month after month we are gaining momentum. We have acquired a bit more than €12 million of new projects since the beginning of the year. Uh, they are projects that will bring growth in the long term. And we have a lot of traction right now in discussions, both with existing customers who are reducing their supplier base and moving more projects to us, but also with new customers who recognize our capabilities. Here we have two factories that are in the forefront, Chuchu and Sierra, where we have quite a lot of interest for the Medtech & Life Science segment. I will hand over to Kai for the financials.

Kai Valo
11:01 - 16:02

Thank you and good morning. Okay, moving forward from my side. First picture is showing them. We observed a waterfall effect from the operating profit of last year to the operating profit of this year. Um, uh. Second quarter. And what is this showing? The strong agility we have with expenses allows us to nearly match them with revenues. Despite revenues dropping to 47.88 million, we've been almost able to adjust expenses similarly. This indicates that nearly all expenses have been variable, as is typical in the EMS business. And, therefore, we have been able to defend the operating margin, ending up at 7.1% in comparison to last year's 7.22%, with strong compression volumes. What is remarkable here is the balance sheet comparison to the end of last year. Uh, two things. Uh, inventories have been lowered by 4.1 million since 2020, which of course is good. Very strong improvement there. At the same time, it has been converted to cash. So, we have almost 20 million more in cash on hand. And here is the cash flow. Net cash from operating activities in the quarter. Very, very strong. 37.2 million of positive cash flow. In the first half of the quarter, we achieved a positive cash flow of 47.7 million. And that was driven by about 25 million of positive inventory, meaning reduction of inventories, development. And if looking at the last four quarters. In one year, we achieved a total of 92 million in positive cash flow, and approximately half of that came from improvements in inventory. And the other half, of course, stems from the strong profitability. And the net debt improved, following the positive cash flow. Net debt is at the level of 29.2 million, and it has been lowered from last year by 60 million, almost double from 87 million a year ago. We have very strong liquidity. We have nearly 90 million of unused credit facilities. And besides that, 40 million in cash on hand. So, almost 130 million of total liquidity at the end of the first half. And the net debt at the same time is 0.4. When? A year ago, it was 11.15. Equity, which strengthens more equity, also contributed to the total assets or the balance sheet value being lower, due to reduced inventories. Net debt gearing, naturally, came down with the lower interest-bearing liabilities and with an increase in cash, leading to a return on equity. We have higher equity. The compression figure is higher. Of course, the euro operating profit and net profit, following that, are a bit lower with the system impacting the percentage. On the other hand, the earnings per share are still on a fairly good level. Uh oh, point 17 in comparison to 4.22 a year ago. And back to you, Christophe. Thank you.

Christophe Sut
16:05 - 17:42

Thank you. We continue to focus on the recovery of the market and will start to follow up very closely. Customer data is rebounding. Uh, we have a few focus areas. We have said before, Energy & Cleantech and Medtech & Life Science are the areas where we have started to create focus, and we have begun to see momentum. So we'll continue on that one. We want to secure profitability. Our attention on efficiency will continue. I think that if we look at the last three quarters, it's evident that we have gained building accountability across the organization, ensuring that people and teams make progress every day on being more efficient. And that's something that we can keep with us no matter the business cycle. And then we are continuing to gear ourselves for growth. As I presented, we have a healthy financial situation that allows us now to build a pipeline for acquisition and potential M&A. And that's what we have started to work on and are currently focusing on. We adjusted our guidance a few weeks ago, and now have a target of 780 to 840 million in revenue, with a profit level of 54 to 61 million for this year. I will now open up the floor to questions.

Pasi Hiedanpää
17:44 - 17:49

Thank you, Christophe. Just a second.

Unknown 2
17:50 - 17:51

Welcome, everyone. Today, we will be discussing Scanfil's performance for the second quarter of 2024.

Pasi Hiedanpää
17:52 - 18:00

What do you see in your American operations during the quarter? And how do you view the demand situation going forward?

Unknown 2
18:03 - 18:03

Thank you for joining us today for this webcast concerning Scanfil's financial performance for the second quarter of 2024.

Christophe Sut
18:04 - 20:05

Yeah, so, two questions. In the American situation, we have started to fill the factory with an existing customer that needed manufacturing in the US. Uh, so this is ramping up. I mean, every month we have more units built out of that unit. So that's a positive development. At the same time, we are starting to secure local contracts that are new to us. That will also ramp up in the second part. So I will say that we are very positive about that investment, and obviously it takes time to receive the payment from it. Let's say it follows the milestone we were aiming for, and we ramp up volume and start to gain new customers at those facilities, which is positive. Uh, when it comes to the demand and outlook. As I mentioned, let's take a step back and look at Q2. It was a very volatile quarter. And that's probably also why I'm so proud of the profit level we delivered with the team. By volatile, I mean that it's not like it landed where we thought it would land, but within the mix of customers, there were a lot of pluses and minuses, which means that in reality, we had to adjust all the time. I mean, it was plus minus plus minus. It was volatile, sometimes rebounding better than we anticipated. Sometimes people are not coming back to the level we were hoping for. So that's just a bit of the story; then looking forward, I mean, we see some segments coming back. Medtech is clearly showing signs of recovery. And then on other aspects, I mean, we have seen signs of a return to better forecasts, but I think it's still a bit early to be super enthusiastic, yet I believe that we can see improvement step by step. Some customers are transitioning out of this phase, and we believe it will materialize within the next six months.

Pasi Hiedanpää
20:07 - 20:30

Thank you, Christophe. Your response? Uh, can we discuss one new project with an estimated value of €40 million in Q2 and €84 million in H1? At the same time, some existing projects scale down or sell off.

Unknown 2
20:31 - 20:32

Or up.

Pasi Hiedanpää
20:32 - 20:41

So, what transpired before this elaboration?

Christophe Sut
20:41 - 22:04

Yeah. But thanks for that question. I think it's a question everyone would want to ask. So, the one that asked it really is helping all of us. Uh, thanks for asking. Uh, two things I would like to explain. I mean, we would have loved to give you comparable numbers, but we realized that last year, we made an effort to start tracking new projects and their impact more accurately, and now we have two quarters where we have been robust in those efforts. So now we have started sharing, which means, unfortunately, we could not share historical data in that context. Which means, as we go forward, and you receive these numbers every quarter, you will get a much better understanding. Okay, what Scanfil needs to win in order to deliver the goals it plans to deliver is clear. What I can say to help you a bit is what we estimate based on what we have today, which is probably needing 10% of our revenue every year in quite new contracts in order to maintain our position. And then what comes on top of that is growth. So those are elements you can consider when you want to materialize a little bit. Okay, what has come about. And if you take that, then you realize that 84 million in half a year is a very good start. If we continue at this pace for the second part, then we will conclude with a very nice year. So that's what I can say on that topic; it will be okay.

Pasi Hiedanpää
22:06 - 22:17

I think it will. Thank you. Besides volumes returning as the market recovers, what do you see as the most important lever to improve? To keep improving the margin?

Unknown 2
22:19 - 22:20

Yes.

Christophe Sut
22:21 - 23:08

I think there are two things. We have set the margin corridor between 7 and 8, and I think we will stick to that because we also want to win market share. So that's an element when it comes to improving the margin, and we continue to see improvement coming from the modernization of our factory. I would say today that the True Factory is the best in our portfolio. But we are still investing to improve the other factories, so that will continue. We believe that digitalization and automation bring long-term improvement in efficiency and therefore help us to increase our profitability and our competitiveness.

Unknown 2
23:10 - 23:11

Okay. Thank you. Yes.

Pasi Hiedanpää
23:12 - 23:24

A question about the price and mix effect. What was the price mix effect on revenue growth in Q2, or is the decline in net sales mainly volume-driven?

Christophe Sut
23:25 - 24:34

Yes, I think the main challenge we faced in Q2, as I mentioned before, is if you compare Q2 this year to Q2 last year, it involves two elements. There was a boom in some of the industries. We saw where people were expecting growth levels in the high double-digit range. For example, when I think about Energy & Cleantech, it was growing about 30-40%. We know that long-term, we expect double-digit growth from that segment. But starting with a one, not with a three. This obviously changes the comparables significantly and poses challenges to the recovery. When we examine the decrease in revenue, it is attributable to lower product delivery, which signifies two things. It means that we still have room in our factory to increase capacity and create growth. But it also means that we have managed, despite this decrease in added value services, to be very efficient in what we have delivered. This webcast event presented by Scanfil covers the company's financial performance for the second quarter of 2024.

Pasi Hiedanpää
24:39 - 24:51

Thank you. About the markets, how do you see your European market share developing in the quarter? So, has there been any changes in the market share?

Christophe Sut
24:52 - 25:40

I think that when we consider the European market, it is evident. I will say we have a. It's a complex question. So, I will try not to get lost in too many details, but I will say that we have been maintaining our position quite nicely. In a few subsegments, we are actually gaining momentum. I think for us it's very clear that Energy & Cleantech, as you saw, we gain more and more new contracts, and also in Medtech & Life Science, we create real momentum. So I think that on a European basis, I'm not sure I can talk only about Europe. It's probably on a global basis. We believe we are gaining momentum and position in the two segments I mentioned.

Pasi Hiedanpää
25:43 - 26:00

Thank you for the outlook. Is market demand weaker now than it was on June 10th, when the new guidance was given? So, have there been any changes in the market?

Christophe Sut
26:00 - 26:30

As I said, it's very volatile. You should also appreciate that we are in the middle of the summer. There are many customers that have not even come back. So I think it's very difficult to comment on the difference between June and the beginning of August. I mean, many people are aware, but as I said, we have seen signs of recovery from some customers. But it's very early to say. I mean, many people are still on vacation.

Pasi Hiedanpää
26:32 - 26:44

Uh, two questions regarding the inventories. Is it fair to assume that there are still some 10 million to release in the inventories going forward for this year?

Unknown 2
26:45 - 26:45

I think?

Pasi Hiedanpää
26:45 - 26:47

Very specific question.

Christophe Sut
26:48 - 26:57

I think it's a very specific question. I think it's fair to assume that we will continue to improve our inventory position, and we are working towards that. Definitely.

Pasi Hiedanpää
26:59 - 27:07

And regarding the same, I do expect that the desired inventory level will be reached before the end of the year.

Christophe Sut
27:10 - 27:12

Uh, can you take it once more, please?

Pasi Hiedanpää
27:13 - 27:25

Uh, do you expect the desired inventory level to be reached before the end of the year? So, they are trying to model how much more cash would actually be coming in from the inventories.

Christophe Sut
27:26 - 27:35

I think we will not give a specific number at this stage. But as I said before, we believe that, yes, it will continue to improve towards the end of the year.

Pasi Hiedanpää
27:39 - 27:55

Uh, check on Medtech & Life Science to recover first. Do you expect the industrial or Energy & Cleantech to recover second? Or how do you see the customer forecasts in these two segments in Europe over the next 6 to 9 months?

Christophe Sut
27:56 - 28:28

Yeah, I think that in Energy & Cleantech, we have an extremely dynamic portfolio and we have started quite a few significant new projects. So, in the coming 12 months, they will all pay off. So, we are very positive about that segment. Then, industrial is a mix of very many different subsegments. But we believe that some of which have bottomed out and will gradually come back. But I will say, in terms of recovery, probably Energy & Cleantech is the one that has the highest potential.

Pasi Hiedanpää
28:31 - 28:44

And then there was a question regarding actually the projects for one as a comparison year, but we do not disclose those comparison figures. So just pointing that out again.

Christophe Sut
28:45 - 28:47

So, I like it.

Pasi Hiedanpää
28:48 - 29:16

Opportunity to ask? Yes, you did. Yeah, any more questions? So yes, there is one more actually, uh, what have you seen from your clients with employment solutions such as heat pumps? Uh, during Q2? So getting a better grip on, uh, energy-saving solutions and the demand in that segment.

Christophe Sut
29:16 - 30:05

Yeah, I mean, what you saw in the segment that was Energy & Cleantech, uh, was slow for us in the quarter. And it was driven, as I mentioned before, by two elements. One was, uh, the comparables of last year which were incredibly high, uh but also a distorting effect. Uh, then, depending on customers, we start to see, first of all, we continue to see interest in new projects. So, this business continues to flourish. There are still activities to be prepared for the future. And therefore, there is a belief that customer demand will return. And then some customers have started to move forward a little bit. But it is still early, and the second quarter was challenging from that perspective.

Unknown 2
30:08 - 30:08

Okay.

Pasi Hiedanpää
30:08 - 30:18

Thank you. If there are no further questions, I hand it over to you, Christophe, for the summary. So please go ahead.

Christophe Sut
30:19 - 32:33

Uh, thank you. As a summary, as I said during the Q&A, I think we see signs of gradual recovery. And it's led by Medtech and Life Science, where we have very clear momentum being built. We are also quite pleased with the new deals we have won during the first half of the year. That was significant. And that was also good in the quarter, 40 million in the quarter, we believe is positive and shows that we are there with our customers, following them, helping them, and they appreciate that. I mean, it's the deal they give us. It's the price they give us. It feels good; it feels really good. And I'm also very proud of the operating margin. We reached 7.1% in the current market situation, not only with the lower volume, but also, as you heard, with the volatility we had to experience during the quarter, I think it's extremely hard work from everyone to reach that. And I would really like to thank everyone for that effort. And then, net cash flow from operations was positive, which only means that we have a positive financial situation, very healthy debt level. That is, again, very low, allowing us to be prepared to finance growth. We have started activities in that field. So as I said before, we are now bringing up new customers as part of our segment strategy that we have implemented. We are gaining new projects as we speak and have a healthy pipeline of new customers and new customer projects. So, that's very pleasing to see. At the same time, we have started to work hard on growth, on the organic obviously as I have mentioned before, but also on the inorganic. And we hope to start making progress in the future. With that, I think it was a challenging quarter, challenging market situation, but a very good effort from all teams. I want to thank you for listening today. And please reach out to Pasi if you have any more questions.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…